AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells

被引:420
作者
Sun, M
Wang, G
Paciga, JE
Feldman, RI
Yuan, ZQ
Ma, XL
Shelley, SA
Jove, R
Tsichlis, PN
Nicosia, SV
Cheng, JQ
机构
[1] Univ S Florida, Coll Med, Dept Pathol & Lab Med, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, Mol Oncol Program, Tampa, FL 33612 USA
[3] H Lee Moffitt Canc Ctr, Tampa, FL USA
[4] Berlex Biosci, Dept Canc Res, Richmond, CA USA
[5] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
关键词
D O I
10.1016/S0002-9440(10)61714-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Extensive studies have demonstrated that the Akt/AKT1 pathway is essential for cell survival and inhibition of apoptosis; however, alterations of Akt/AKT1 in human primary tumors have not been well documented. in this report, significantly increased AKT1 kinase activity was detected in primary carcinomas of prostate (16 of 30), breast (19 of 50), and ovary (11 of 28). The results were confirmed by Western blot and immunohistochemical staining analyses with phospho-Ser473 A-kt antibody. The majority of AKT1-activated tumors are high grade and stage III/IV (13 of 16 prostate, 15 of 19 breast, and 8 of 11 ovarian carcinomas). Previous studies showed that wild-type AKT1 was unable to transform NIH3T3 cells. To demonstrate the biological significance of AKT1 activation in human cancer, constitutively activated AKT1 (Myr-Akt) was introduced into NIH3T3 cells. Overexpression of Myr-Akt in the stably transfected cells resulted in malignant phenotype, as determined by growth in soft agar and tumor formation in nude mice. These data indicate that AKT1 kinase, which is frequently activated in human cancer, is a determinant in oncogenesis and a potential target for cancer intervention.
引用
收藏
页码:431 / 437
页数:7
相关论文
共 37 条
  • [1] AHMED NN, 1993, ONCOGENE, V8, P1957
  • [2] Role of translocation in the activation and function of protein kinase B
    Andjelkovic, M
    Alessi, DR
    Meier, R
    Fernandez, A
    Lamb, NJC
    Frech, M
    Cron, P
    Cohen, P
    Lucocq, JM
    Hemmings, BA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (50) : 31515 - 31524
  • [3] The Akt kinase:: Molecular determinants of oncogenicity
    Aoki, M
    Batista, O
    Bellacosa, A
    Tsichlis, P
    Vogt, PK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) : 14950 - 14955
  • [4] Akt activation by growth factors is a multiple-step process: the role of the PH domain
    Bellacosa, A
    Chan, TO
    Ahmed, NN
    Datta, K
    Malstrom, S
    Stokoe, D
    McCormick, F
    Feng, JN
    Tsichlis, P
    [J]. ONCOGENE, 1998, 17 (03) : 313 - 325
  • [5] MOLECULAR ALTERATIONS OF THE AKT2 ONCOGENE IN OVARIAN AND BREAST CARCINOMAS
    BELLACOSA, A
    DEFEO, D
    GODWIN, AK
    BELL, DW
    CHENG, JQ
    ALTOMARE, DA
    WAN, MH
    DUBEAU, L
    SCAMBIA, G
    MASCIULLO, V
    FERRANDINA, G
    PANICI, PB
    MANCUSO, S
    NERI, G
    TESTA, JR
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (04) : 280 - 285
  • [6] BELLACOSA A, 1993, ONCOGENE, V8, P745
  • [7] A RETROVIRAL ONCOGENE, AKT, ENCODING A SERINE-THREONINE KINASE CONTAINING AN SH2-LIKE REGION
    BELLACOSA, A
    TESTA, JR
    STAAL, SP
    TSICHLIS, PN
    [J]. SCIENCE, 1991, 254 (5029) : 274 - 277
  • [8] Stat3 as an oncogene
    Bromberg, JF
    Wrzeszczynska, MH
    Devgan, G
    Zhao, YX
    Pestell, RG
    Albanese, C
    Darnell, JE
    [J]. CELL, 1999, 98 (03) : 295 - 303
  • [9] PROTEIN-KINASE-B (C-AKT) IN PHOSPHATIDYLINOSITOL-3-OH INASE SIGNAL-TRANSDUCTION
    BURGERING, BMT
    COFFER, PJ
    [J]. NATURE, 1995, 376 (6541) : 599 - 602
  • [10] Regulation of cell death protease caspase-9 by phosphorylation
    Cardone, MH
    Roy, N
    Stennicke, HR
    Salvesen, GS
    Franke, TF
    Stanbridge, E
    Frisch, S
    Reed, JC
    [J]. SCIENCE, 1998, 282 (5392) : 1318 - 1321